Equities

Avacta Group PLC

AVCT:LSE

Avacta Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)46.75
  • Today's Change0.00 / 0.00%
  • Shares traded2.50m
  • 1 Year change-60.71%
  • Beta1.8356
Data delayed at least 20 minutes, as of May 01 2024 17:08 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Avacta Group PLC had net income fall 48.92% from a loss of 26.32m to a larger loss of 39.19m despite revenues that grew 228.22% from 2.94m to 9.65m over the same period.
Gross margin54.40%
Net profit margin-262.60%
Operating margin-217.65%
Return on assets-63.18%
Return on equity-143.33%
Return on investment-119.23%
More ▼

Cash flow in GBPView more

In 2022, Avacta Group PLC increased its cash reserves by 59.52%, or 15.59m. Cash Flow from Financing totalled 56.90m or 589.50% of revenues. In addition the company used 16.43m for operations while cash used for investing totalled 25.04m.
Cash flow per share-0.1462
Price/Cash flow per share--
Book value per share0.0826
Tangible book value per share-0.0389
More ▼

Balance sheet in GBPView more

Avacta Group PLC has a Debt to Total Capital ratio of 69.13%, a higher figure than the previous year's 11.04%.
Current ratio0.7137
Quick ratio0.6603
Total debt/total equity2.24
Total debt/total capital0.6913
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.